THE PHARMACOLOGICAL BASIS OF NEUROLEPTIC MALIGNANT SYNDROME

被引：4

作者：

ADDONIZIO, G

机构：

来源：

PSYCHIATRIC ANNALS | 1991年 / 21卷 / 03期

关键词：

D O I：

10.3928/0048-5713-19910301-07

中图分类号：

R749 [精神病学];

学科分类号：

100205 ;

摘要：

引用

页码：152 / &

共 21 条

[1] INCREASED EXTRAPYRAMIDAL SYMPTOMS WITH ADDITION OF LITHIUM TO NEUROLEPTICS [J].

ADDONIZIO, G ;

ROTH, SD ;

STOKES, PE ;

STOLL, PM .

JOURNAL OF NERVOUS AND MENTAL DISEASE, 1988, 176 (11) :682-685

[2] NEUROLEPTIC MALIGNANT SYNDROME - REVIEW AND ANALYSIS OF 115 CASES [J].

ADDONIZIO, G ;

SUSMAN, VL ;

ROTH, SD .

BIOLOGICAL PSYCHIATRY, 1987, 22 (08) :1004-1020

[3] ADVERSE REACTIONS IN TREATMENT WITH LITHIUM-CARBONATE AND HALOPERIDOL [J].

BAASTRUP, PC ;

HOLLNAGEL, P ;

SORENSEN, R ;

SCHOU, M .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1976, 236 (23) :2645-2646

[4] NEUROLEPTIC MALIGNANT SYNDROME CAUSED BY DOPAMINE-DEPLETING DRUGS IN A PATIENT WITH HUNTINGTON DISEASE [J].

BURKE, RE ;

FAHN, S ;

MAYEUX, R ;

WEINBERG, H ;

LOUIS, K ;

WILLNER, JH .

NEUROLOGY, 1981, 31 (08) :1022-1026

[5] LITHIUM-CARBONATE, HALOPERIDOL, AND IRREVERSIBLE BRAIN-DAMAGE [J].

COHEN, WJ ;

COHEN, NH .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1974, 230 (09) :1283-1287

[6]

GELENBERG A, 1988, AM J PSYCHIAT, V14, P5517

[7]

GOLDNEY RD, 1986, AM J PSYCHIAT, V143, P882

[8]

KECK PE, 1987, AM J PSYCHIAT, V144, P1344

[9]

KECK PE, 1989, J CLIN PSYCHIAT, V50, P352

[10]

KECK PE, 1989, ARCH GEN PSYCHIAT, V46, P914

← 1 2 3 →